149 related articles for article (PubMed ID: 8391606)
1. NC-1300, a proton-pump inhibitor, requires gastric acid to exert cytoprotection in rat gastric mucosa.
Arakawa T; Fukuda T; Higuchi K; Koike K; Satoh H; Kobayashi K
Jpn J Pharmacol; 1993 Apr; 61(4):299-302. PubMed ID: 8391606
[TBL] [Abstract][Full Text] [Related]
2. Effect on gastric mucus of the proton pump inhibitor leminoprazole and its cytoprotective action against ethanol-induced gastric injury in rats.
Ishihara K; Ichikawa T; Komuro Y; Ohara S; Hotta K
Arzneimittelforschung; 1994 Jul; 44(7):827-30. PubMed ID: 7945516
[TBL] [Abstract][Full Text] [Related]
3. Cytoprotective effect of NC-1300-O-3 against gastric lesions induced by necrotizing agents in rats.
Matsukura H; Masuda M; Kawaguchi K; Uchida A; Kamishiro T
Jpn J Pharmacol; 1994 May; 65(1):9-18. PubMed ID: 8089937
[TBL] [Abstract][Full Text] [Related]
4. Effects of NC-1300 and its degradation products on gastric secretion and HCl.ethanol-induced gastric lesions in rats.
Okabe S; Akimoto Y; Miyake H; Imada J
Jpn J Pharmacol; 1987 May; 44(1):7-14. PubMed ID: 3626185
[TBL] [Abstract][Full Text] [Related]
5. Gastroprotective activity of the novel proton pump inhibitor lansoprazole in the rat.
Morini G; Grandi D; Arcari ML; Bertaccini G
Gen Pharmacol; 1995 Sep; 26(5):1021-5. PubMed ID: 7557244
[TBL] [Abstract][Full Text] [Related]
6. Effects of NC-1300-B, a new benzimidazole derivative, on hog gastric H+, K+-ATPase, gastric acid secretion and HCl.ethanol-induced gastric lesions in rats.
Okabe S; Akimoto Y; Yamasaki S; Nagai H
Dig Dis Sci; 1988 Nov; 33(11):1425-34. PubMed ID: 2846250
[TBL] [Abstract][Full Text] [Related]
7. Cytoprotective effects of NC-1300 and omeprazole on Hcl . ethanol-induced gastric lesions in rats.
Okabe S; Miyake H; Awane Y
Jpn J Pharmacol; 1986 Sep; 42(1):123-33. PubMed ID: 3795613
[TBL] [Abstract][Full Text] [Related]
8. Cytoprotective effect of rabeprazole against ethanol-induced gastric mucosal damage: possible involvement of nitric oxide.
Watanabe T; Higuchi K; Tominaga K; Fujiwara Y; Arakawa T
Drugs Exp Clin Res; 2000; 26(2):41-5. PubMed ID: 10894554
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new benzimidazole derivative, NC-1300-O-3, on gastric secretion and gastroduodenal lesions in rats.
Okabe S; Akimoto Y; Yamasaki S; Kuwahara K
Jpn J Pharmacol; 1991 Apr; 55(4):477-91. PubMed ID: 1832198
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
[TBL] [Abstract][Full Text] [Related]
11. Gastroprotective effects of pantoprazole against experimental mucosal damage.
Blandizzi C; Natale G; Gherardi G; Lazzeri G; Marveggio C; Colucci R; Carignani D; Del Tacca M
Fundam Clin Pharmacol; 2000; 14(2):89-99. PubMed ID: 10796055
[TBL] [Abstract][Full Text] [Related]
12. Gastric antisecretory activity of lansoprazole in different experimental models: comparison with omeprazole.
Coruzzi G; Adami M; Bertaccini G
Gen Pharmacol; 1995 Sep; 26(5):1027-32. PubMed ID: 7557245
[TBL] [Abstract][Full Text] [Related]
13. Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa.
Fukuda T; Arakawa T; Shimizu Y; Ohtani K; Higuchi K; Kobayashi K
J Clin Gastroenterol; 1995; 20 Suppl 2():S5-7. PubMed ID: 7594340
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds.
Natale G; Lazzeri G; Lubrano V; Colucci R; Vassalle C; Fornai M; Blandizzi C; Del Tacca M
Toxicol Appl Pharmacol; 2004 Feb; 195(1):62-72. PubMed ID: 14962506
[TBL] [Abstract][Full Text] [Related]
15. Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury.
Blandizzi C; Natale G; Gherardi G; Lazzeri G; Marveggio C; Colucci R; Carignani D; Del Tacca M
Dig Dis Sci; 1999 Oct; 44(10):2039-50. PubMed ID: 10548356
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
[TBL] [Abstract][Full Text] [Related]
17. Effect of the proton pump inhibitor, NC-1300, on gastric mucus secretion in rats.
Ohara S; Ohkawa H; Ishihara K; Hotta K; Komuro Y; Okabe H
Scand J Gastroenterol Suppl; 1989; 162():187-9. PubMed ID: 2480636
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and pharmacological analysis of 2-[(2-dimethylaminobenzyl)sulfinyl] benzimidazole (NC-1300), a new proton pump inhibitor.
Okabe S; Higaki E; Higuchi T; Sato M; Hara K
Jpn J Pharmacol; 1986 Feb; 40(2):239-49. PubMed ID: 3009944
[TBL] [Abstract][Full Text] [Related]
19. The effect of a new gastric proton pump inhibitor on serotonin-induced gastric mucosal lesions in rats.
Tsukamoto Y; Nakazawa S; Segawa K; Goto H; Fukui A; Takano K; Hase S; Arisawa T; Osada T; Kawabe Y
Gastroenterol Jpn; 1988 Oct; 23(5):501-5. PubMed ID: 3215434
[TBL] [Abstract][Full Text] [Related]
20. Effects of histamine H2-receptor antagonists and a proton pump inhibitor on the mucosal hydroxyproline content of ethanol-HCl-induced gastric lesions in rats.
Suzuki T; Tsukamoto Y; Goto H; Hase S; Arisawa T; Asai J
Digestion; 1992; 51(3):161-7. PubMed ID: 1387856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
